Reumuth Mary
Insider CIK 1710969 · KALA Chief Financial Officer, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KALA KALA BIO, Inc. | S Sale | 2025-10-23 | 2025-10-24 | 967 | $0.82 | $793 | 28,906 | SEC↗ |
| KALA KALA BIO, Inc. | S Sale | 2025-10-22 | 2025-10-24 | 32,230 | $0.83 | $26.8K | 29,873 | SEC↗ |
| KALA KALA BIO, Inc. | S Sale | 2025-06-24 | 2025-06-26 | 3,631 | $4.01 | $14.6K | 62,100 | SEC↗ |
| KALA KALA BIO, Inc. | S Sale | 2025-06-03 | 2025-06-04 | 2,850 | $3.74 | $10.7K | 65,731 | SEC↗ |
| KALA KALA BIO, Inc. | A Award deriv | 2025-01-06 | 2025-01-07 | 45,200 | — | $0 | 45,200 | SEC↗ |
| KALA KALA BIO, Inc. | S Sale | 2025-01-06 | 2025-01-07 | 1,706 | $7.63 | $13.0K | 68,581 | SEC↗ |
| KALA KALA BIO, Inc. | A Award | 2025-01-06 | 2025-01-07 | 10,100 | — | $0 | 70,287 | SEC↗ |
| KALA KALA BIO, Inc. | S Sale | 2024-06-26 | 2024-06-27 | 4,163 | $4.75 | $19.8K | 60,187 | SEC↗ |
| KALA KALA BIO, Inc. | S Sale | 2024-05-31 | 2024-06-03 | 1,786 | $6.09 | $10.9K | 64,350 | SEC↗ |
| KALA KALA BIO, Inc. | A Award deriv | 2024-01-04 | 2024-01-05 | 20,500 | — | $0 | 20,500 | SEC↗ |
| KALA KALA BIO, Inc. | S Sale | 2024-01-04 | 2024-01-05 | 1,227 | $6.74 | $8.3K | 66,136 | SEC↗ |
| KALA KALA BIO, Inc. | A Award | 2024-01-04 | 2024-01-05 | 4,600 | — | $0 | 67,363 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2023-06-22 | 2023-06-23 | 48,192 | — | $0 | 48,192 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2023-06-22 | 2023-06-23 | 36,144 | — | $0 | 62,763 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 648 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 1,841 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 578 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 1,399 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 2,999 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 3,059 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 1,813 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 2,399 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2023-05-31 | 2023-06-02 | 14,736 | — | $0 | 26,619 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2023-03-14 | 2023-03-15 | 432 | — | $0 | 432 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | S Sale | 2023-01-04 | 2023-01-06 | 60 | $28.54 | $1.7K | 11,883 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2023-01-04 | 2023-01-06 | 9,525 | — | $0 | 11,943 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | S Sale | 2022-10-26 | 2022-10-28 | 194 | $6.51 | $1.3K | 2,418 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | S Sale | 2022-06-27 | 2022-06-29 | 2,613 | $0.37 | $967 | 130,595 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 2,850 | $1.30 | $3.7K | 133,208 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 153,000 | — | $0 | 153,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | S Sale | 2021-10-26 | 2021-10-28 | 9,449 | $1.80 | $17.0K | 136,058 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | S Sale | 2021-06-28 | 2021-06-29 | 2,452 | $5.77 | $14.1K | 145,507 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2021-01-04 | 2021-01-05 | 90,667 | — | $0 | 90,667 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2021-01-04 | 2021-01-05 | 22,666 | — | $0 | 147,959 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2020-10-26 | 2020-10-28 | 61,000 | — | $0 | 125,293 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2020-06-25 | 2020-06-29 | 16,000 | — | $0 | 64,293 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | M Exercise deriv | 2020-06-09 | 2020-06-11 | 11,520 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | M Exercise deriv | 2020-06-09 | 2020-06-11 | 15,360 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | M Exercise deriv | 2020-06-09 | 2020-06-11 | 5,077 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | M Exercise deriv | 2020-06-09 | 2020-06-11 | 11,520 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | M Exercise | 2020-06-09 | 2020-06-11 | 11,520 | $2.30 | $26.5K | 16,336 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | M Exercise | 2020-06-09 | 2020-06-11 | 5,077 | $5.21 | $26.5K | 21,413 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | M Exercise | 2020-06-09 | 2020-06-11 | 15,360 | $2.30 | $35.3K | 36,773 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | M Exercise | 2020-06-09 | 2020-06-11 | 11,520 | $2.30 | $26.5K | 48,293 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2020-01-02 | 2020-01-03 | 120,000 | — | $0 | 120,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2019-01-02 | 2019-01-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2018-02-07 | 2018-02-09 | 70,000 | — | $0 | 70,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2017-07-19 | 2017-07-21 | 28,973 | — | $0 | 28,973 | SEC↗ |